- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07937397
Acute Effects of Green Tea Intake on Countermovement Jump and Cognitive Performance in Taekwondo Athletes (green-tea)
Acute Effects of Green Tea Intake on Countermovement Jump and Cognitive Performance in Taekwondo Athletes: A Randomized, Placebo-Controlled Crossover Trial
This study aims to investigate the acute effects of green tea intake on countermovement jump performance and cognitive performance in male Taekwondo athletes. A randomized, placebo-controlled, three-condition crossover design will be used. Each participant will complete control, placebo, and green tea conditions in a randomized and counterbalanced order, with a washout period of at least 72 hours between sessions. CMJ performance will be assessed as the primary outcome, followed by the Stroop test as the secondary outcome.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Following a familiarization session, participants will complete three experimental sessions. At the beginning of each session, body weight will be measured. Participants will then receive the assigned condition and wait for 60 minutes. After a standardized warm-up, CMJ performance will be assessed using the My Jump Lab application. Following a 5-minute standardized rest period, cognitive performance will be evaluated using the Stroop test. The order of experimental conditions will be randomized and counterbalanced among participants.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Healthy male Taekwondo athletes aged 18-25 years.
At least 3 years of licensed Taekwondo experience.
Regular Taekwondo training at least 3 days per week during the previous 6 months.
Willingness to participate voluntarily and provide written informed consent.
Exclusion Criteria:
Presence of any chronic disease.
Cardiovascular, metabolic, or neurological disorders.
Lower-extremity injury or surgery within the previous 6 months.
Regular medication use.
Known sensitivity to caffeine or green tea.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control
Participants will complete the control condition without receiving green tea or placebo. |
Participants will not receive green tea extract or placebo during the control condition. They will follow the same experimental procedures and assessment schedule as in the other conditions, including a 60-minute waiting period before the standardized warm-up and performance assessments. |
|
Placebo Comparator: Placebo
Participants will receive a placebo preparation |
Participants will receive a placebo orally 60 minutes before the performance assessments. |
|
Experimental: Green Tea
Participants will receive a standardized green tea extract preparation. |
Participants will receive green tea extract orally 60 minutes before the performance assessments. The intervention will be administered according to the study protocol. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Countermovement Jump (CMJ) Performance
Time Frame: Immediately after the 5-minute rest period following the CMJ assessment.
|
Cognitive performance will be assessed using the Stroop test. Performance will be evaluated based on reaction time and accuracy. |
Immediately after the 5-minute rest period following the CMJ assessment.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognitive Performance Assessed by the Stroop Test
Time Frame: Immediately after the 5-minute rest period following the CMJ assessment.
|
Cognitive performance will be assessed using the Stroop test. Reaction time and accuracy (number of correct responses and errors) will be recorded. |
Immediately after the 5-minute rest period following the CMJ assessment.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- INU-ARCH-2026-25
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.